Article
Irvine, Calif. - Sweat has a new enemy. Botox (botulinum toxin type A), developed by Allergan, has been approved by the U.S. Food and Drug Administration (FDA) to treat hyperhidrosis.
Practice What You Preach: A Clinician's Guide to Chemical Peels
The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition
Four Key Factors When Buying Dermatology Devices
The Cutaneous Connection: Cosmetic Dermatology: Procedures and Practice
The Future of Body Contouring: Insights from David Goldberg, MD, JD
Phase 3b Data Reinforce Rapid, Long-Lasting Efficacy of RelabotulinumtoxinA for Glabellar Lines